Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge

Dendritic cells (DCs) ‘pulsed’ with an appropriate antigen may elicit an antitumour immune response in mouse models. However, while attempting to develop a DC immunotherapy protocol for the treatment of breast cancer based on the tumour-associated MUC1 glycoforms, we found that unpulsed DCs can affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimshaw, M J, Papazisis, K, Picco, G, Bohnenkamp, H, Noll, T, Taylor-Papadimitriou, J, Burchell, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259193/
https://www.ncbi.nlm.nih.gov/pubmed/18253127
http://dx.doi.org/10.1038/sj.bjc.6604221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259193/
https://www.ncbi.nlm.nih.gov/pubmed/18253127
http://dx.doi.org/10.1038/sj.bjc.6604221

Ejemplares similares